New insights into immunomodulation via overexpressing lipoic acid synthase as a therapeutic potential to reduce atherosclerosis

Tian, SM; Nakamura, J; Hiller, S; Simington, S; Holley, DW; Mota, R; Willis, MS; Bultman, SJ; Luft, JC; DeSimone, JM; Jia, ZQ; Maeda, N; Yi, XW

Yi, XW (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Yi, XW (corresponding author), Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27599 USA.

VASCULAR PHARMACOLOGY, 2020; 133 ():

Abstract

Atherosclerosis is a systemic chronic inflammatory disease. Many antioxidants including alpha-lipoic acid (LA), a product of lipoic acid synthase (Lia......

Full Text Link